EU OKs First-Line Osimertinib+Chemo for EGFR+ Advanced NSCLC
The European Commission has approved Tagrisso (osimertinib; AstraZeneca) combined with pemetrexed and platinum-based chemotherapy for the first-line treatment of adult ...
Read moreDetailsThe European Commission has approved Tagrisso (osimertinib; AstraZeneca) combined with pemetrexed and platinum-based chemotherapy for the first-line treatment of adult ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info